Kiniksa Pharmaceuticals International (KNSA) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $7.8 million.
- Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization fell 354.1% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 354.1%. This contributed to the annual value of $8.2 million for FY2024, which is 524.08% up from last year.
- According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization is $7.8 million, which was down 354.1% from $7.8 million recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization registered a high of $8.2 million during Q4 2024, and its lowest value of $5.0 million during Q1 2021.
- In the last 5 years, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization had a median value of $7.4 million in 2023 and averaged $7.1 million.
- Per our database at Business Quant, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization skyrocketed by 2498.01% in 2022 and then crashed by 354.1% in 2025.
- Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization stood at $5.9 million in 2021, then increased by 15.96% to $6.9 million in 2022, then rose by 13.5% to $7.8 million in 2023, then grew by 5.24% to $8.2 million in 2024, then decreased by 4.58% to $7.8 million in 2025.
- Its last three reported values are $7.8 million in Q3 2025, $7.8 million for Q2 2025, and $7.8 million during Q1 2025.